Endovascular Treatment of Renal Artery Thrombosis in Living-Donor Kidney Transplant Recipient With Severe COVID-19 Disease

• Type: Another Publication in an International Scientific Journal
• Date: 2022

Authors

Veterano, C (Author) Other; Antunes, I (Author) Other; Coelho, A (Author) FMUP; Silva, I (Author) Other; Almeida, R (Author) Other; Pinto, PS (Author) Other

Journal

The Journal is awaiting validation by the Administrative Services.

Title: Journal of Endovascular Therapy

ISSN: 15266028

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 0 Citations

Other information

Authenticus ID: P-00V-Z9H

DOI: 10.1177/15266028211068756

Abstract (EN): Purpose: Coronavirus disease 2019 (COVID-19) patients have a higher prevalence of micro-and macrovascular thrombotic events. However, the underlying mechanism for the increased thrombotic risk is not completely understood. Solid organ transplant recipients infected with SARS-CoV-2 may have an exponential increase in thrombotic risk and the best management strategy is unknown. Case Report: A female kidney transplant recipient presented with allograft's renal artery thrombosis after a recent COVID-19 infection. Due to the risk of kidney failure or exclusion, catheter directed thrombolysis was performed. Residual thrombus was excluded using an endoprosthesis with an excellent result. There were no adverse events and kidney function improved. Conclusion: This paper reports the endovascular treatment of renal artery thrombosis in a living-donor kidney transplant recipient with severe COVID-19 disease.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 5